Zoetis’ Cytopoint is first monoclonal antibody (mAb) therapy approved in the European Union for veterinary use
European Commission has granted marketing authorization for Zoetis’ Cytopoint (lokivetmab), the first monoclonal antibody (mAb) therapy approved in the European Union for... Read More